Tumor oxygen dynamics: Correlation of in vivo MRI with histological findings

Neoplasia

Volumn 5, Issue 4, 2003, Pages 308-318

  Zhao, Dawen ^a   Ran, Sophia ^a   Constantinescu, Anca ^a   Hahn, Eric W ^a   Mason, Ralph P ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

19F nuclear magnetic resonance (NMR); Hypoxia; Immunohistochemistry; Oxygen tension; Prostate tumor

Indexed keywords

PIMONIDAZOLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER THERAPY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FLUOROCARBON RELAXOMETRY USING ECHO PLANAR IMAGING FOR DYNAMIC OXYGEN MAPPING; GROWTH RATE; HISTOLOGY; HYPOXIA; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN CONSUMPTION; OXYGEN TENSION; PRIORITY JOURNAL; PROSTATE TUMOR; RAT; TUMOR GROWTH; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM;

EID: 0041854257     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1476-5586(03)80024-6     Document Type: Article

References (57)

1. Brown JM, and Giaccia AJ (1994). Tumor hypoxia: the picture has changed in the 1990s. Int J Radiat Biol 65, 95-102.
2. Denekamp J (1989). Physiological hypoxia and its influence on radiotherapy. In The Biological Basis of Radiotherapy, 2nd ed. GG Steel, GE Adams, and A Horwich, Eds. Elsevier, Amsterdam. pp. 115-43.
3. Höckel M, Schlenger K, Aral B, Mitze M, Schäffer U, and Vaupel P (1996). Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 56, 4509-515.
4. Sartorelli AC (1988). Therapeutic attack of hypoxic cells of solid tumors: presidential address. Cancer Res 48, 775-78.
5. De Jaeger K, Kavanagh MC, and Hill RP (2001). Relationship of hypoxia to metastatic ability in rodent tumors. Br J Cancer 84, 1280-285.
6. Höckel M, and Vaupel P (2001). Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 93, 266-76.
7. Stone HB, Brown JM, Phillips T, and Sutherland RM (1993). Oxygen in human tumors: correlations between methods of measurement and response to therapy. Radiat Res 136, 422-34.
8. Hunjan S, Zhao D, Constantinescu A, Hahn EW, Antich PP, and Mason RP (2001). Tumor oximetry: demonstration of an enhanced dynamic mapping procedure using fluorine-19 echo planar magnetic resonance imaging in the Dunning prostate R3327-AT1 rat tumor. Int J Radiat Oncol Biol Phys 49, 1097-108.
9. Zhao D, Constantinescu A, Hahn EW, and Mason RP (2002). Differential oxygen dynamics in two diverse Dunning prostate R3327 rat tumor sublines (MAT-Lu and HI) with respect to growth and respiratory challenge. Int J Radiat Oncol Biol Phys 53, 744-56.
10. Isaacs J, Isaacs W, Feitz W, and Scheres J (1986). Establishment and characterization of 7 Dunning prostate cancer cell lines and their use in developing methods for predicting metastatic ability of prostate cancer. Prostate 9, 261-81.
11. Vaupel P, Kallinowski F, and Okunieff P (1989). Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 49, 6449-465.
12. Raleigh JA, Chou SC, Arteel GE, and Horsman MR (1999). Comparison among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors. Radiat Res 151, 580-89.
13. Evans SM, Hahn S, Pook DR, Jenkins WT, Chalian AA, Zhang P, Stevens C, Weber R, Weinstein G, Benjamin I, Mirza N, Morgan M, Rubin S, McKenna WG, Lord EM, and Koch CJ (2000). Detection of hypoxia in human squamous cell carcinoma by EF5 binding. Cancer Res 60, 2018-2024.
14. Ljungkvist ASE, Bussink J, Rijken PFJW, Raleigh JA, Denekamp J, and Van Der Kogel AJ (2000). Changes in tumor hypoxia measured with a double hypoxic marker technique. Int J Radiat Oncol Biol Phys 48, 1529-538.
15. Peschke P, Hahn EW, Wenz F, Lohr F, Braunschweig F, Wolber G, Zuna I, and Wannenmacher M (1998). Differential sensitivity of three sublines of the rat Dunning prostate tumor system R3327 to radiation and/or local tumor hyperthermia. Radiat Res 150, 423-30.
16. Hahn EW, Peschke P, Mason RP, Babcock EE, and Antich PP (1993). Isolated tumor growth in a surgically formed skin pedicle in the rat: a new tumor model for NMR studies. Magn Reson Imaging 11, 1007-1017.
17. Weidner N (1995). Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 147, 9-19.
18. Yeh KA, Biade S, Lanciano RM, Brown DQ, Fenning MC, Babb JS, Hanks GE, and Chapman JD (1995). Polarographic needle electrode measurements of oxygen in rat prostate carcinomas: accuracy and reproducibility. Int J Radiat Oncol Biol Phys 33, 111-18.
19. Chapman JD, McPhee MS, Walz N, Chetner MP, Stobbe CC, Soderlind K, Arnfield M, Meeker BE, Trimble L, and Allen PS (1991). Nuclear magnetic resonance spectroscopy and sensitizer-adduct measurements of photodynamic therapy-induced ischemia in solid tumors. J Natl Cancer Inst 83, 1650-659.
20. Thorndyke C, Meeker B, Thomas G, Laky W, McPhee M, and Chapman J (1985). The radiation sensitivities of R3327-H and -AT1 rat prostate adenocarcinomas. J Urol 134, 191-98.
21. Mason RP, Constantinescu A, Hunjan S, Le D, Hahn EW, Antich PP, Blum C, and Peschke P (1999). Regional tumor oxygenation and measurement of dynamic changes. Radiat Res 152, 239-49.
22. Zhao D, Constantinescu A, Hahn EW, and Mason RP (2001). Tumor oxygen dynamics with respect to growth and respiratory challenge: investigation of the Dunning prostate R3327-HI tumor. Radiat Res 156, 510-20.
23. Song Y, Constantinescu A, and Mason RP (2002). Dynamic breast tumor oximetry: the development of prognostic radiology. Technol Cancer Res Treat 1, 1-8.
24. Rofstad EK (2000). Microenvironment-induced cancer metastasis. Int J Radiat 76, 589-605.
25. Birner P, Schindl P, Obermair A, Plank C, Breitenecker G, and Oberhuber G (2000). Overexpression of hypoxia-inducible factor 1 is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res 60, 4693-696.
26. Fyles A, Milosevic M, Hedley M, Pintile M, Levin W, Manchul L, and Hill RP (2002). Tumor hypoxia has independent predictor impact only on patients with node-negative cervix cancer. J Clin Oncol 20, 680-87.
27. Brizel DM, Scully SP, Harrelson JM, Layfield LJ, Bean JM, Prosnitz LR, and Dewhirst MW (1996). Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 56, 941-43.
28. 2 tension measurements. Cancer Res 51, 3316-322.
29. Hohenberger P, Felger C, Haensch W, and Schlag PM (1998). Tumor oxygenation correlates with molecular growth determinants in breast cancer. Breast Cancer Res Treat 48, 97-106.
30. Thews O, Kelleher DK, Lecher B, and Vaupel P (1998). Blood flow, oxygenation, metabolic and energetic status in different clonal subpopulations of a rat rhabdomyosarcoma. Int J Oncol 13, 205-11.
31. Young S, Marshall R, and Hill R (1988). Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proc Natl Acad Sci USA 85, 9533-537.
32. Cairns RA, Kalliomaki T, and Hill RP (2001). Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumors. Cancer Res 61, 8903-908.
33. Kaanders JHAM, Wijffels KIEM, Marres HAM, Ljungkvist ASE, Pop LAM, van den Hoogen FJA, de Wilde PCM, Bussink J, Raleigh JA, and van der Kogel AJ (2002). Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer. Cancer Res 62, 7066-7074.
34. 2 study. Cancer 89, 2018-2024.
35. Eble MJ, Lohr F, Wenz F, Krems B, Bachert P, and Peschke P (1995). Tissue oxygen tension distribution in two sublines of the Dunning prostate tumor R3327. In Tumor Oxygenation. PW Vaupel, DK Kelleher, and M, Gunderoth, Eds. Funktionsanalyse Biologischer Systeme, Gustav Fischer Verlag, Stuttgart. pp. 95-105.
36. Kallman R, and Dorie M (1986). Tumor oxygenation and reoxygenation during radiation therapy: importance in predicting tumor response. Int J Radiat Oncol Biol Phys 12, 681-85.
37. Fenton BM (1997). Effects of carbogen plus fractionated irradiation on KHT tumor oxygenation. Radiother Oncol 44, 183-90.
38. Zhao D, Constantinescu A, Chang CK, Hahn EW, and Mason RP (2003). Correlation of tumor oxygen dynamics with radiation response of the Dunning prostate R3327-HI tumors. Radiat Res 159, 621-31.
39. Kaanders JHAM, Pop LAM, Marres HAM, Bruaset I, van den Hoogen FJA, Merkx MAW, and van der Kogel AJ (2002). ARCON: experience in 215 patients with advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 52, 769-78.
40. 19F NMR spectroscopy of hexafluorobenzene. Int J Radiat Oncol Biol Phys 40, 161-71.
41. 19F NMR indicator of tumor oxygenation. NMR Biomed 9, 125-34.
42. Bussink J, Kaanders JHAM, Strik AM, Vojnovic B, and van der Kogel AJ (2000). Optical sensor-based oxygen tension measurements correspond with hypoxia marker binding in three human tumor xenograft lines. Radiat Res 154, 547-55.
43. Evans SM, Hahn S, Hahn SM, Magarelli DP, and Koch CJ (2001). Hypoxic heterogeneity in human tumors: EF5 binding, vasculature, necrosis, and proliferation. Am J Clin Oncol 24, 467-72.
44. Lyng H, Sundfor K, and Rofstad EK (1997). Oxygen tension in human tumours measured with polarographic needle electrodes and its relationship to vascular density, necrosis and hypoxia. Radiother Oncol 44, 163-69.
45. Olive PL (1994). Radiation-induced reoxygenation in the SCC VII murine tumor: evidence for a decrease in oxygen consumption and an increase in tumor perfusion. Radiother Oncol 32, 37-46.
46. Jenkins WT, Evans SM, and Koch CJ (2000). Hypoxia and necrosis in rat 9L glioma and Morris 7777 hepatoma tumors: comparative measurements using EF5 binding and the Eppendorf needle electrode. Int J Radiat Oncol Biol Phys 46, 1005-1017.
47. Bennewith KL, Raleigh JA, and Durand RE (2002). Orally administered pimonidazole to label hypoxic tumor cells. Cancer Res 62, 6827-830.
48. Folkman J (1974). Tumor angiogenesis. Adv Cancer Res 19, 331-58.
49. Semenza GL (2002). HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med 8, S62-67.
50. Zhao D, Constantinescu A, Jiang L, Hahn EW, and Mason RP (2001). Prognostic radiology: quantitative assessment of tumor oxygen dynamics by MRI. Am J Clin Oncol 24, 462-66.
51. Mason RP, Ran S, and Thorpe PE (2002). Quantitative assessment of tumor oxygen dynamics: molecular imaging for prognostic radiology. J Cell Biochem 87, 45-53.
52. 2 mapping. J Biomed Opt 8, 53-62.
53. Howe FA, Robinson SP, Rodrigues LM, and Griffiths JR (1999). Flow and oxygenation dependent (FLOOD) contrast MR imaging to monitor the response of rat tumors to carbogen breathing. Magn Reson Imaging 17, 1307-318.
54. 2) inside tumors? Magn Reson Med 48, 980-86.
55. Fan X, River JN, Zamora M, Al-Hallaq HA, and Karczmar GS (2002). Effect of carbogen on tumor oxygenation: combined fluorine-19 and proton MRI measurements. Int J Radiat Oncol Biol Phys 54, 1202-209.
56. Cooper RA, Carrington BM, Loncaster JA, Todd SM, Davidson SE, Logue JP, Luthra AD, Jones AP, Stratford I, Hunter RD, and West CML (2000). Tumor oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix. Radiother Oncol 57, 53-59.
57. Wang Z, Su M-Y, and Nalcioglu O (2002). Applications of dynamic contrast enhanced MRI in oncology: measurement of tumor oxygen tension. Technol Cancer Res Treat 1, 29-38.